Is Atea Pharmaceuticals, Inc. (AVIR) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 0.4% / 30% | 98.8% / 30% | 0.0% / 30% | N/A | ✗ NOT HALAL |
| DJIM | 0.4% / 33% | 98.8% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| MSCI | 0.4% / 33% | 97.9% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| S&P | 0.4% / 33% | 98.8% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| FTSE | 0.4% / 33% | 97.9% / 33% | 0.0% / 50% | N/A | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 0.0% | |
| Operating Margin | 0.0% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -44.3% | |
| Return on Assets (ROA) | -28.8% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$132M |
| Free Cash Flow | -$132M |
| Total Debt | $843,000 |
| Debt-to-Equity | 0.3 |
| Current Ratio | 7.8 |
| Total Assets | $315M |
Price & Trading
| Last Close | $5.33 |
| 50-Day MA | $4.76 |
| 200-Day MA | $3.67 |
| Avg Volume | 551K |
| Beta | 0.3 |
|
52-Week Range
$2.46
| |
About Atea Pharmaceuticals, Inc. (AVIR)
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections. Its lead product candidate is the regimen of bemnifosbuvir, a nucleotide NS5B inhibitor, and ruzasvir, an NS5A inhibitor, which is in Phase 3 clinical trial for the treatment of hepatitis C virus (HCV). The company also developing AT-587, that is in Phase 1 clinical trial for the treatment of chronic HEV infection. In addition, it offers a proprietary platform of nucleosides and nucleotides for virology, medicinal chemistry, and antiviral drug development. The company has a license agreement with MSD International GmbH for the development, manufacture, and commercialization of ruzasvir. Atea Pharmaceuticals, Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Atea Pharmaceuticals, Inc. (AVIR) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Atea Pharmaceuticals, Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Atea Pharmaceuticals, Inc.'s debt ratio?
Atea Pharmaceuticals, Inc.'s debt ratio is 0.4% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 0.4%.
What are Atea Pharmaceuticals, Inc.'s key financial metrics?
Atea Pharmaceuticals, Inc. has a market capitalization of $408M. Return on equity stands at -44.3%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.